For: |
Tang RX, Luo DJ, Sun AH, Yan J. Diversity of |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i30/4816.htm |
Number | Citing Articles |
1 |
G.Sh. Isaeva, R.I. Valieva. Biological characteristics and virulence of Helicobacter pylori. Clinical Microbiology and Antimicrobial Chemotherapy 2018; 20(1): 14 doi: 10.36488/cmac.2018.1.14-23
|
2 |
Jianzhong Zhang. Molecular Medical Microbiology. 2024; : 1133 doi: 10.1016/B978-0-12-818619-0.00120-9
|
3 |
Kangle Zhai, Yanan Gong, Lu Sun, Lihua He, Zhijing Xue, Yaming Yang, Mengyang Fang, Jianzhong Zhang. DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection. Helicobacter 2023; 28(2) doi: 10.1111/hel.12955
|
4 |
Jacek Baj, Alicja Forma, Monika Sitarz, Piero Portincasa, Gabriella Garruti, Danuta Krasowska, Ryszard Maciejewski. Helicobacter pylori Virulence Factors—Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment. Cells 2020; 10(1): 27 doi: 10.3390/cells10010027
|
5 |
Inês Vitoriano, Alexandra Rocha‐Gonçalves, Teresa Carvalho, Mónica Oleastro, Cecília R. C. Calado, Mónica Roxo‐Rosa. Antigenic Diversity Among Portuguese Clinical Isolates of Helicobacter pylori. Helicobacter 2011; 16(2): 153 doi: 10.1111/j.1523-5378.2011.00825.x
|
6 |
Jo‐Lewis Banga Ndzouboukou, Qing Lei, Nadeem Ullah, Yandi Zhang, Ling Hao, Xionglin Fan. Helicobacter pylori adhesins: HpaA a potential antigen in experimental vaccines for H. pylori. Helicobacter 2021; 26(1) doi: 10.1111/hel.12758
|
7 |
Xueyong Huang, Bianli Xu, Guangcai Duan, Chunhua Song. The rOmp22–HpaA Fusion Protein Confers Protective Immunity Against Helicobacter pylori in Mice. Current Microbiology 2013; 67(4): 487 doi: 10.1007/s00284-013-0390-x
|
8 |
Maliheh Safavi, Reyhaneh Sabourian, Alireza Foroumadi. Treatment of <i>Helicobacter pylori</i> infection: Current and future insights. World Journal of Clinical Cases 2016; 4(1): 5-19 doi: 10.12998/wjcc.v4.i1.5
|
9 |
Farnaz Fahimi, Mohammad Reza Tohidkia, Mehdi Fouladi, Reza Aghabeygi, Naser Samadi, Yadollah Omidi. Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy. BioImpacts 2017; 7(1): 59 doi: 10.15171/bi.2017.08
|
10 |
Luo Wei, Wang Qian, Zhang Xiao Fang, Gu Dong Mei, Zhang Wei Feng, Yuan Chun Hui. Evaluation of the Diagnostic Value of FliD, a <i>Helicobacter pylori</i> Flagellar Protein. Japanese Journal of Infectious Diseases 2022; 75(5): 454 doi: 10.7883/yoken.JJID.2021.795
|
11 |
Ziba V. Malekshahi, Seyed Latif Mousavi Gargari, Iraj Rasooli, Walead Ebrahimizadeh. Treatment of Helicobacter pylori infection in mice with oral administration of egg yolk-driven anti-UreC immunoglobulin. Microbial Pathogenesis 2011; 51(5): 366 doi: 10.1016/j.micpath.2011.06.002
|
12 |
Maria Felicia Soluri, Simone Puccio, Giada Caredda, Paolo Edomi, Mario Milco D’Elios, Fabio Cianchi, Arianna Troilo, Claudio Santoro, Daniele Sblattero, Clelia Peano. Defining the Helicobacter pylori Disease-Specific Antigenic Repertoire. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.01551
|
13 |
Leon Chien‐Wei Lin, Saborni Chattopadhyay, Jung‐Chen Lin, Che‐Ming Jack Hu. Advances and Opportunities in Nanoparticle‐ and Nanomaterial‐Based Vaccines against Bacterial Infections. Advanced Healthcare Materials 2018; 7(13) doi: 10.1002/adhm.201701395
|
14 |
Abeer Ahmed Qaed Ahmed, Roberta Besio, Lin Xiao, Antonella Forlino. Outer Membrane Vesicles (OMVs) as Biomedical Tools and Their Relevance as Immune-Modulating Agents against H. pylori Infections: Current Status and Future Prospects. International Journal of Molecular Sciences 2023; 24(10): 8542 doi: 10.3390/ijms24108542
|
15 |
V. V. Novikov, V. A. Lapin, D. A. Melentiev, E. V. Mokhonova. Features of the human immune response to Helicobacter pylori infection. MediAl 2019; (2): 55 doi: 10.21145/2225-0026-2019-2-55-69
|
16 |
Alaa M. Elgohary, Nourhan M. Gomaa, Mohamed A. Ibrahim, Hagar S. Ahmed, Shimaa M. Ibraheem, Mustafa H. Frag. Gastrointestinal Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 4: 117 doi: 10.1007/16833_2023_183
|
17 |
Nasrin Mirzaei, Farkhondeh Poursina, Sharareh Moghim, Niloufar Rashidi, Hajieh Ghasemian Safaei. The study ofH. pyloriputative candidate factors for single- and multi-component vaccine development. Critical Reviews in Microbiology 2017; 43(5): 631 doi: 10.1080/1040841X.2017.1291578
|
18 |
Kuo-Shun Shih, Chih-Chang Lin, Hsiao-Fang Hung, Yu-Chi Yang, Chung-An Wang, Kee-Ching Jeng, Hua-Wen Fu, William R. Abrams. One-Step Chromatographic Purification of Helicobacter pylori Neutrophil-Activating Protein Expressed in Bacillus subtilis. PLoS ONE 2013; 8(4): e60786 doi: 10.1371/journal.pone.0060786
|
19 |
Nidhi Gupta, Shweta Maurya, Harshvardhan Verma, Vijay K. Verma. Unraveling the factors and mechanism involved in persistence: Host‐pathogen interactions in Helicobacter pylori. Journal of Cellular Biochemistry 2019; 120(11): 18572 doi: 10.1002/jcb.29201
|
20 |
Haiying Gu. Role of Flagella in the Pathogenesis of Helicobacter pylori. Current Microbiology 2017; 74(7): 863 doi: 10.1007/s00284-017-1256-4
|
21 |
Abbas Shapouri Moghaddam, Kiarash Ghazvini, Abbas Bahador, Mohammad Derakhshan, Azad Khaledi. Cloning, expression, and purification of HpaA-CagA fusion recombinant protein of Helicobacter pylori in E. coli BL 21 strain. Gene Reports 2019; 16: 100417 doi: 10.1016/j.genrep.2019.100417
|
22 |
Morteza Milani, Yaeghob Sharifi, Mohammad Rahmati-Yamchi, Mohammad H Somi, Abolfazl Akbarzadeh. Immunology and vaccines and nanovaccines forHelicobacter pyloriinfection. Expert Review of Vaccines 2015; 14(6): 833 doi: 10.1586/14760584.2015.1008460
|
23 |
A.A. Svistunov, M.A. Osadchuk, E.D. Mironova, E.S. Ogibenina. Helicobacter pylori infection as a risk factor for gastrointestinal cancer. Profilakticheskaya meditsina 2021; 24(11): 105 doi: 10.17116/profmed202124111105
|
24 |
Gabriella Feilstrecker Balani, Mariana dos Santos Cortez, Jayme Euclydes Picasky da Silveira Freitas, Fabrício Freire de Melo, Ana Carla Zarpelon-Schutz, Kádima Nayara Teixeira. Immune response modulation in inflammatory bowel diseases by <i>Helicobacter pylori</i> infection. World Journal of Gastroenterology 2023; 29(30): 4604-4615 doi: 10.3748/wjg.v29.i30.4604
Abstract(501) |
Core Tip(527) |
Full Article(HTML)(2610)
|
Full Article with Cover (PDF)-2203K(127)
|
Full Article (Word)-1634K(97)
|
Audio-726K(7)
|
Peer-Review Report-219K(51)
|
Answering Reviewers-71K(63)
|
Full Article (PDF)-1980K(171)
|
Full Article (XML)-229K(58)
|
Times Cited (6)
|
Total Visits (5646)
|
Open
|